Home › Funds › IRIDIAN ASSET MANAGEMENT LLC/CT › LH

IRIDIAN ASSET MANAGEMENT LLC/CT position in LH

LABCORP HOLDINGS INC · Health Care

IRIDIAN ASSET MANAGEMENT LLC/CT reported holding 1,771 shares of LH (LABCORP HOLDINGS INC) in its Q2 2026 13F filing — a position valued at US$496K, representing 0.17% of its reported portfolio and ranking #38 among its reported holdings. IRIDIAN ASSET MANAGEMENT LLC/CT has disclosed LH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.77K sh
Reported value held$495.88K
Portfolio Weight0.17%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How IRIDIAN ASSET MANAGEMENT LLC/CT's LH position evolved

IRIDIAN ASSET MANAGEMENT LLC/CT first disclosed a stake in LH in Q3 2023 at 100,516 shares (US$20.2M). Across 12 filings, IRIDIAN ASSET MANAGEMENT LLC/CT increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,771 shares valued at US$496K — a reduction of -1,056 shares quarter over quarter.. Notable position changes include a 75% trim in Q4 2023 (shares fell 4% over the following quarter), a 79% trim in Q1 2025 (shares rose 13% over the following quarter), a 37% trim in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 100.52K $20.21M New
Q4 2023 24.85K $5.65M Reduce
Q1 2024 23.12K $5.05M Reduce
Q2 2024 31.61K $6.43M Add
Q3 2024 22.22K $4.96M Reduce
Q4 2024 20.50K $4.70M Reduce
Q1 2025 4.22K $982.86K Reduce
Q2 2025 3.91K $1.03M Reduce
Q3 2025 3.99K $1.15M Add
Q4 2025 3.64K $914.21K Reduce
Q1 2026 2.83K $754.27K Reduce
Q2 2026 1.77K $495.88K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 30 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.35B), Boston Partners (US$854.2M), Allspring Global Investments Holdings, LLC (US$635.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has IRIDIAN ASSET MANAGEMENT LLC/CT held LH?

IRIDIAN ASSET MANAGEMENT LLC/CT has disclosed LH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is IRIDIAN ASSET MANAGEMENT LLC/CT's current position in LH?

As of Q2 2026, IRIDIAN ASSET MANAGEMENT LLC/CT holds 1.77K shares of LH (LABCORP HOLDINGS INC), valued at $495.88K, representing 0.17% of its reported portfolio and ranking #38.

Has IRIDIAN ASSET MANAGEMENT LLC/CT been buying or selling LH?

In the latest 13F filing (Q2 2026), IRIDIAN ASSET MANAGEMENT LLC/CT reduced its position in LH.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.